American Oncology Network Inc. (AONC) — Capital Reinvestment Ratio

Latest as of December 2024: 0.53x

American Oncology Network Inc. (AONC) has a Capital Reinvestment Ratio of 0.53x as of December 2024, meaning it reinvests 1% of its operating cash flow ($11.93 Million) in capital expenditures ($6.33 Million). See how leveraged is American Oncology Network Inc.'s balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.53x
Capex / Operating Cash Flow

Operating Cash Flow

$11.93 Million
USD

Capital Expenditures

$6.33 Million
USD

Data as of

Dec 2024
Most recent filing

American Oncology Network Inc. Capital Reinvestment Ratio (2020–2020)

This chart tracks American Oncology Network Inc.'s Capital Reinvestment Ratio across 1 annual periods. Check total reinvestment intensity of American Oncology Network Inc. to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for American Oncology Network Inc. (2020–2020)

Year-by-year Capital Reinvestment Ratio for American Oncology Network Inc. from 2020 to 2020. For live market cap and broader valuation context, see American Oncology Network Inc. (AONC) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.33x $37.24 Million $12.22 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow